Search

A study conducted at Southern Medical University in Guangzhou, China, explored the use of salinomycin, an antibiotic, in treating hyperuricemic nephropathy (HN). The research found that salinomycin can regulate uric acid levels, protect the kidneys, and modulate gut microbiota in mice with HN. The study suggests that salinomycin may be a promising treatment option for HN in clinical settings. The findings were published in Chemico-Biological Interactions and have been peer-reviewed. [Extracted from the article]